-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Parkinson's disease (PD) is the most common neurodegenerative movement disorder.
Parkinson's disease (PD) is the most common neurodegenerative movement disorder.
More and more evidences show that inflammatory bowel disease (IBD) and Parkinson's disease (PD) have similar pathological mechanisms and closely related risk factors for disease
Ren-Shi Xu et al.
They searched the PubMed, Embase, and Cochrane databases, and searched for observational studies on IBD and PD published from the beginning to October 2019
They searched the PubMed, Embase, and Cochrane databases, and searched for observational studies on IBD and PD published from the beginning to October 2019
After excluding confounding factors and heterogeneity studies, the total risk of PD in patients with IBD was significantly higher than that of the general population (adjusted hazard ratio [RR]=1.
Patients over 65 years of age with inflammatory bowel disease are associated with the development of Parkinson's disease
Patients over 65 years of age with inflammatory bowel disease are associated with the development of Parkinson's disease
Patients under 65 years of age with inflammatory bowel disease are associated with the development of Parkinson's disease
Patients under 65 years of age with inflammatory bowel disease are associated with the development of Parkinson's disease
However, older patients (>65 years old) with IBD (adjusted HR=1.
The Meta analysis showed that there is a certain correlation between IBD IBD and PD, suggesting that IBD may moderately increase the risk of PD, especially in patients over 65 years of age
Zhu Y, Yuan M, Liu Y, Yang F, Chen WZ, Xu ZZ, Xiang ZB, Xu RS.
